Cam Gallagher
Known title: DirectorCIK: 0001557832
Cam Gallagher's purchase track record
Cam Gallagher has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/29/2025 | IRD | $324K | +118.6% | +104.0% | +7.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Leerink Partners initiates coverage of Zentalis at Outperform. Leerink Partners has begun covering Zentalis Pharmaceuticals with an Outperform rating and a price target of $8. This new analyst note places the target above the current average analyst estimate of $6.89. The move adds to the recent analyst activity surrounding the stock, which is currently trading near its 52-week range midpoint.
Transaction History
| IRD | ▲ Buy | Option Exercise | 784,314 | $902K | 9/8/2026 | View on chart |
| IRD | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 | View on chart |
| IRD | ▲ Buy | Grant | 67,000 | $0 | 1/6/2026 | View on chart |
| IRD | ▲ Buy | Grant | 33,000 | $0 | 12/31/2025 | View on chart |
| IRD | ▲ Buy | Open Market | 81,000 | $160K | 12/29/2025 | View on chart |
| IRD | ▲ Buy | Open Market | 83,000 | $163K | 12/29/2025 | View on chart |
| IRD | ▲ Buy | Grant | 869,565 | $1000K | 8/25/2025 | View on chart |
| IRD | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 | View on chart |
| IRD | ▲ Buy | Grant | 784,314 | — | 3/24/2025 | View on chart |
| IRD | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,597 | $115K | 5/31/2024 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,173 | $13K | 2/12/2024 | View on chart |
| ZNTL | ▼ Sell | Open Market | 11,552 | $133K | 2/2/2024 | View on chart |
| ZNTL | ▲ Buy | Grant | 192,500 | $0 | 2/1/2024 | View on chart |
| IRD | ▲ Buy | Grant | 10,976 | $0 | 6/6/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,242 | $244K | 5/31/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 18,526 | $486K | 5/31/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 8,501 | $170K | 2/14/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,332 | $68K | 2/13/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,428 | $210K | 2/6/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 572 | $13K | 2/6/2023 | View on chart |
| ZNTL | ▲ Buy | Grant | 161,092 | $0 | 2/1/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,500 | $229K | 1/17/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 500 | $12K | 1/17/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,700 | $204K | 1/5/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 300 | $6K | 1/5/2023 | View on chart |
| IRD | ▼ Sell | Other | 1,574 | $0 | 1/4/2023 | View on chart |
| ZNTL | ▼ Sell | Open Market | 11,600 | $264K | 11/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 900 | $21K | 11/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 12,374 | $292K | 11/8/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 12,343 | $292K | 11/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 157 | $4K | 11/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 12,500 | $294K | 10/17/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 10,000 | $226K | 10/6/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 7,004 | $154K | 10/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 5,496 | $125K | 10/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 8,866 | $216K | 9/16/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,134 | $28K | 9/16/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 8,426 | $212K | 9/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,074 | $104K | 9/15/2022 | View on chart |
| ZNTL | ▲ Buy | Grant | 111,072 | $0 | 5/30/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,335 | $169K | 4/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,196 | $113K | 4/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 100 | $5K | 4/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,369 | $217K | 4/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,578 | $190K | 3/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 5,322 | $225K | 3/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 100 | $4K | 3/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,477 | $426K | 3/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 523 | $24K | 3/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,264 | $167K | 2/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 5,366 | $280K | 2/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,370 | $72K | 2/15/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,079 | $104K | 2/14/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 259 | $13K | 2/14/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,850 | $243K | 2/14/2022 | View on chart |
| ZNTL | ▲ Buy | Grant | 7,595 | $0 | 2/10/2022 | View on chart |
| ZNTL | ▲ Buy | Grant | 8,203 | $0 | 2/10/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,290 | $121K | 2/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 6,460 | $346K | 2/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,250 | $68K | 2/7/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,434 | $212K | 1/18/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,842 | $117K | 1/18/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,300 | $84K | 1/18/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,424 | $214K | 1/18/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,641 | $277K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 700 | $53K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 900 | $67K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,397 | $175K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,106 | $85K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,156 | $90K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 100 | $8K | 1/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,100 | $79K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,900 | $139K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,117 | $83K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 311 | $24K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 520 | $40K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 527 | $42K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,001 | $214K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,524 | $119K | 12/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 10,000 | $713K | 12/6/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 6,614 | $496K | 11/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,400 | $182K | 11/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 986 | $76K | 11/15/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,506 | $206K | 11/5/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 5,094 | $423K | 11/5/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,400 | $201K | 11/5/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,900 | $123K | 10/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,820 | $322K | 10/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 616 | $42K | 10/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,664 | $175K | 10/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 6,241 | $420K | 9/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,759 | $256K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Opus Genetics to Present at Euretina 2026
Opus Genetics announced it will present data at the Euretina 2026 conference. This event is relevant as it provides a platform for the company to share scientific updates on its gene therapy programs. The stock currently trades below the average analyst target price, with a 52-week range spanning from $1.32 to $7.07.
Opus Genetics to Present at Euretina 2026. Opus Genetics announced it will present data at the Euretina 2026 conference. This event is relevant as it provides a platform for the company to share scientific updates on its gene therapy programs. The stock currently trades below the average analyst target price, with a 52-week range spanning from $1.32 to $7.07.